Deferoxamine Market, Global Outlook and Forecast 2022-2028

March 2022 | 78 pages | ID: DE3468865277EN
Market Monitor Global

Abstracts

Deferoxamine (DFOA), sold under the brand name Desferal, is a medication that binds iron and aluminium. It is specifically used in iron overdose, hemochromatosis either due to multiple blood transfusions or an underlying genetic condition, and aluminium toxicity in people on dialysis. It is used by injection into a muscle, vein, or under the skin

This report contains market size and forecasts of Deferoxamine in global, including the following market information:

Global Deferoxamine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Deferoxamine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Deferoxamine companies in 2021 (%)

The global Deferoxamine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection for Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Deferoxamine include APP Pharmaceuticals, Hospira, Watson Laboratories, Novartis Pharmaceuticals, Fresenius Kabi, Gland Pharma, West-Ward Pharms and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deferoxamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Deferoxamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Deferoxamine Market Segment Percentages, by Type, 2021 (%)

• Injection for Solution
• Powder for Solution
• Lyophilized for Solution

Global Deferoxamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Deferoxamine Market Segment Percentages, by Application, 2021 (%)

• Aluminum Overload
• Chronic Iron Overload
• Chronic Aluminum Overload
• Acute Iron Intoxication

Global Deferoxamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Deferoxamine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Deferoxamine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Deferoxamine revenues share in global market, 2021 (%)

Key companies Deferoxamine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Deferoxamine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• APP Pharmaceuticals
• Hospira
• Watson Laboratories
• Novartis Pharmaceuticals
• Fresenius Kabi
• Gland Pharma
• West-Ward Pharms
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Deferoxamine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Deferoxamine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DEFEROXAMINE OVERALL MARKET SIZE

2.1 Global Deferoxamine Market Size: 2021 VS 2028
2.2 Global Deferoxamine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Deferoxamine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Deferoxamine Players in Global Market
3.2 Top Global Deferoxamine Companies Ranked by Revenue
3.3 Global Deferoxamine Revenue by Companies
3.4 Global Deferoxamine Sales by Companies
3.5 Global Deferoxamine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Deferoxamine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Deferoxamine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Deferoxamine Players in Global Market
  3.8.1 List of Global Tier 1 Deferoxamine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Deferoxamine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Deferoxamine Market Size Markets, 2021 & 2028
  4.1.2 Injection for Solution
  4.1.3 Powder for Solution
  4.1.4 Lyophilized for Solution
4.2 By Type - Global Deferoxamine Revenue & Forecasts
  4.2.1 By Type - Global Deferoxamine Revenue, 2017-2022
  4.2.2 By Type - Global Deferoxamine Revenue, 2023-2028
  4.2.3 By Type - Global Deferoxamine Revenue Market Share, 2017-2028
4.3 By Type - Global Deferoxamine Sales & Forecasts
  4.3.1 By Type - Global Deferoxamine Sales, 2017-2022
  4.3.2 By Type - Global Deferoxamine Sales, 2023-2028
  4.3.3 By Type - Global Deferoxamine Sales Market Share, 2017-2028
4.4 By Type - Global Deferoxamine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Deferoxamine Market Size, 2021 & 2028
  5.1.2 Aluminum Overload
  5.1.3 Chronic Iron Overload
  5.1.4 Chronic Aluminum Overload
  5.1.5 Acute Iron Intoxication
5.2 By Application - Global Deferoxamine Revenue & Forecasts
  5.2.1 By Application - Global Deferoxamine Revenue, 2017-2022
  5.2.2 By Application - Global Deferoxamine Revenue, 2023-2028
  5.2.3 By Application - Global Deferoxamine Revenue Market Share, 2017-2028
5.3 By Application - Global Deferoxamine Sales & Forecasts
  5.3.1 By Application - Global Deferoxamine Sales, 2017-2022
  5.3.2 By Application - Global Deferoxamine Sales, 2023-2028
  5.3.3 By Application - Global Deferoxamine Sales Market Share, 2017-2028
5.4 By Application - Global Deferoxamine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Deferoxamine Market Size, 2021 & 2028
6.2 By Region - Global Deferoxamine Revenue & Forecasts
  6.2.1 By Region - Global Deferoxamine Revenue, 2017-2022
  6.2.2 By Region - Global Deferoxamine Revenue, 2023-2028
  6.2.3 By Region - Global Deferoxamine Revenue Market Share, 2017-2028
6.3 By Region - Global Deferoxamine Sales & Forecasts
  6.3.1 By Region - Global Deferoxamine Sales, 2017-2022
  6.3.2 By Region - Global Deferoxamine Sales, 2023-2028
  6.3.3 By Region - Global Deferoxamine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Deferoxamine Revenue, 2017-2028
  6.4.2 By Country - North America Deferoxamine Sales, 2017-2028
  6.4.3 US Deferoxamine Market Size, 2017-2028
  6.4.4 Canada Deferoxamine Market Size, 2017-2028
  6.4.5 Mexico Deferoxamine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Deferoxamine Revenue, 2017-2028
  6.5.2 By Country - Europe Deferoxamine Sales, 2017-2028
  6.5.3 Germany Deferoxamine Market Size, 2017-2028
  6.5.4 France Deferoxamine Market Size, 2017-2028
  6.5.5 U.K. Deferoxamine Market Size, 2017-2028
  6.5.6 Italy Deferoxamine Market Size, 2017-2028
  6.5.7 Russia Deferoxamine Market Size, 2017-2028
  6.5.8 Nordic Countries Deferoxamine Market Size, 2017-2028
  6.5.9 Benelux Deferoxamine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Deferoxamine Revenue, 2017-2028
  6.6.2 By Region - Asia Deferoxamine Sales, 2017-2028
  6.6.3 China Deferoxamine Market Size, 2017-2028
  6.6.4 Japan Deferoxamine Market Size, 2017-2028
  6.6.5 South Korea Deferoxamine Market Size, 2017-2028
  6.6.6 Southeast Asia Deferoxamine Market Size, 2017-2028
  6.6.7 India Deferoxamine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Deferoxamine Revenue, 2017-2028
  6.7.2 By Country - South America Deferoxamine Sales, 2017-2028
  6.7.3 Brazil Deferoxamine Market Size, 2017-2028
  6.7.4 Argentina Deferoxamine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Deferoxamine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Deferoxamine Sales, 2017-2028
  6.8.3 Turkey Deferoxamine Market Size, 2017-2028
  6.8.4 Israel Deferoxamine Market Size, 2017-2028
  6.8.5 Saudi Arabia Deferoxamine Market Size, 2017-2028
  6.8.6 UAE Deferoxamine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 APP Pharmaceuticals
  7.1.1 APP Pharmaceuticals Corporate Summary
  7.1.2 APP Pharmaceuticals Business Overview
  7.1.3 APP Pharmaceuticals Deferoxamine Major Product Offerings
  7.1.4 APP Pharmaceuticals Deferoxamine Sales and Revenue in Global (2017-2022)
  7.1.5 APP Pharmaceuticals Key News
7.2 Hospira
  7.2.1 Hospira Corporate Summary
  7.2.2 Hospira Business Overview
  7.2.3 Hospira Deferoxamine Major Product Offerings
  7.2.4 Hospira Deferoxamine Sales and Revenue in Global (2017-2022)
  7.2.5 Hospira Key News
7.3 Watson Laboratories
  7.3.1 Watson Laboratories Corporate Summary
  7.3.2 Watson Laboratories Business Overview
  7.3.3 Watson Laboratories Deferoxamine Major Product Offerings
  7.3.4 Watson Laboratories Deferoxamine Sales and Revenue in Global (2017-2022)
  7.3.5 Watson Laboratories Key News
7.4 Novartis Pharmaceuticals
  7.4.1 Novartis Pharmaceuticals Corporate Summary
  7.4.2 Novartis Pharmaceuticals Business Overview
  7.4.3 Novartis Pharmaceuticals Deferoxamine Major Product Offerings
  7.4.4 Novartis Pharmaceuticals Deferoxamine Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Pharmaceuticals Key News
7.5 Fresenius Kabi
  7.5.1 Fresenius Kabi Corporate Summary
  7.5.2 Fresenius Kabi Business Overview
  7.5.3 Fresenius Kabi Deferoxamine Major Product Offerings
  7.5.4 Fresenius Kabi Deferoxamine Sales and Revenue in Global (2017-2022)
  7.5.5 Fresenius Kabi Key News
7.6 Gland Pharma
  7.6.1 Gland Pharma Corporate Summary
  7.6.2 Gland Pharma Business Overview
  7.6.3 Gland Pharma Deferoxamine Major Product Offerings
  7.6.4 Gland Pharma Deferoxamine Sales and Revenue in Global (2017-2022)
  7.6.5 Gland Pharma Key News
7.7 West-Ward Pharms
  7.7.1 West-Ward Pharms Corporate Summary
  7.7.2 West-Ward Pharms Business Overview
  7.7.3 West-Ward Pharms Deferoxamine Major Product Offerings
  7.7.4 West-Ward Pharms Deferoxamine Sales and Revenue in Global (2017-2022)
  7.7.5 West-Ward Pharms Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Deferoxamine Major Product Offerings
  7.8.4 Novartis Deferoxamine Sales and Revenue in Global (2017-2022)
  7.8.5 Novartis Key News

8 GLOBAL DEFEROXAMINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Deferoxamine Production Capacity, 2017-2028
8.2 Deferoxamine Production Capacity of Key Manufacturers in Global Market
8.3 Global Deferoxamine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DEFEROXAMINE SUPPLY CHAIN ANALYSIS

10.1 Deferoxamine Industry Value Chain
10.2 Deferoxamine Upstream Market
10.3 Deferoxamine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Deferoxamine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Deferoxamine in Global Market
Table 2. Top Deferoxamine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Deferoxamine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Deferoxamine Revenue Share by Companies, 2017-2022
Table 5. Global Deferoxamine Sales by Companies, (K Units), 2017-2022
Table 6. Global Deferoxamine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Deferoxamine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Deferoxamine Product Type
Table 9. List of Global Tier 1 Deferoxamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Deferoxamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Deferoxamine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Deferoxamine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Deferoxamine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Deferoxamine Sales (K Units), 2017-2022
Table 15. By Type - Global Deferoxamine Sales (K Units), 2023-2028
Table 16. By Application – Global Deferoxamine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Deferoxamine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Deferoxamine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Deferoxamine Sales (K Units), 2017-2022
Table 20. By Application - Global Deferoxamine Sales (K Units), 2023-2028
Table 21. By Region – Global Deferoxamine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Deferoxamine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Deferoxamine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Deferoxamine Sales (K Units), 2017-2022
Table 25. By Region - Global Deferoxamine Sales (K Units), 2023-2028
Table 26. By Country - North America Deferoxamine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Deferoxamine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Deferoxamine Sales, (K Units), 2017-2022
Table 29. By Country - North America Deferoxamine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Deferoxamine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Deferoxamine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Deferoxamine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Deferoxamine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Deferoxamine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Deferoxamine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Deferoxamine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Deferoxamine Sales, (K Units), 2023-2028
Table 38. By Country - South America Deferoxamine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Deferoxamine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Deferoxamine Sales, (K Units), 2017-2022
Table 41. By Country - South America Deferoxamine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Deferoxamine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Deferoxamine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Deferoxamine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Deferoxamine Sales, (K Units), 2023-2028
Table 46. APP Pharmaceuticals Corporate Summary
Table 47. APP Pharmaceuticals Deferoxamine Product Offerings
Table 48. APP Pharmaceuticals Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Hospira Corporate Summary
Table 50. Hospira Deferoxamine Product Offerings
Table 51. Hospira Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Watson Laboratories Corporate Summary
Table 53. Watson Laboratories Deferoxamine Product Offerings
Table 54. Watson Laboratories Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Novartis Pharmaceuticals Corporate Summary
Table 56. Novartis Pharmaceuticals Deferoxamine Product Offerings
Table 57. Novartis Pharmaceuticals Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Fresenius Kabi Corporate Summary
Table 59. Fresenius Kabi Deferoxamine Product Offerings
Table 60. Fresenius Kabi Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Gland Pharma Corporate Summary
Table 62. Gland Pharma Deferoxamine Product Offerings
Table 63. Gland Pharma Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. West-Ward Pharms Corporate Summary
Table 65. West-Ward Pharms Deferoxamine Product Offerings
Table 66. West-Ward Pharms Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Deferoxamine Product Offerings
Table 69. Novartis Deferoxamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Deferoxamine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Deferoxamine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Deferoxamine Production by Region, 2017-2022 (K Units)
Table 73. Global Deferoxamine Production by Region, 2023-2028 (K Units)
Table 74. Deferoxamine Market Opportunities & Trends in Global Market
Table 75. Deferoxamine Market Drivers in Global Market
Table 76. Deferoxamine Market Restraints in Global Market
Table 77. Deferoxamine Raw Materials
Table 78. Deferoxamine Raw Materials Suppliers in Global Market
Table 79. Typical Deferoxamine Downstream
Table 80. Deferoxamine Downstream Clients in Global Market
Table 81. Deferoxamine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Deferoxamine Segment by Type
Figure 2. Deferoxamine Segment by Application
Figure 3. Global Deferoxamine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Deferoxamine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Deferoxamine Revenue, 2017-2028 (US$, Mn)
Figure 7. Deferoxamine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Deferoxamine Revenue in 2021
Figure 9. By Type - Global Deferoxamine Sales Market Share, 2017-2028
Figure 10. By Type - Global Deferoxamine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Deferoxamine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Deferoxamine Sales Market Share, 2017-2028
Figure 13. By Application - Global Deferoxamine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Deferoxamine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Deferoxamine Sales Market Share, 2017-2028
Figure 16. By Region - Global Deferoxamine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Deferoxamine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Deferoxamine Sales Market Share, 2017-2028
Figure 19. US Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Deferoxamine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Deferoxamine Sales Market Share, 2017-2028
Figure 24. Germany Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 25. France Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Deferoxamine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Deferoxamine Sales Market Share, 2017-2028
Figure 33. China Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 37. India Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Deferoxamine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Deferoxamine Sales Market Share, 2017-2028
Figure 40. Brazil Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Deferoxamine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Deferoxamine Sales Market Share, 2017-2028
Figure 44. Turkey Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Deferoxamine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Deferoxamine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Deferoxamine by Region, 2021 VS 2028
Figure 50. Deferoxamine Industry Value Chain
Figure 51. Marketing Channels